Nature Biotechnology presents a Bioentrepreneur Roundtable

 Nature Biotechnology Presents:

Bioentrepreneur Beware: CEO war stories on investor nightmares

 

Venture capital is a key part of growing your biotech startup, but sometimes VCs can work against the interests of company founders and management. We’ve gathered a group of seasoned CEOs, VCs and a venture lawyer to discuss how and why life science ventures can sometimes go haywire. The panel will discuss what can go wrong during the financing process, including term sheets negotiations that seriously dilute equity, rounds that fall through at the last second, investor activism and hostile takeover of board seats. 

Take the opportunity to participate in a lively panel discussion that will explore key issues when borrowing other people’s money and ways that you can ensure investor and management goals synergize for the benefit of your business. 

Panelists: 
Brady Huggett, Business Editor, Nature Biotechnology 
Bruce Cohen
Jennie Mather, CEO, Raven Biotech 
David J. Main, CEO, Aquinox Pharmaceuticals 
John Freund, Skyline Ventures 

 
To register at no cost, visit: http://www.nature.com/natureconferences/biortb-may-2008/index.html

Location

The Meritage Resort, Napa, CA

Contact Information

http://www.nature.com/natureconferences/biortb-may-2008/index.html